Although there is ample evidence that CD74 and MIF are instrumental in the development of autoimmune disorders and some indication that they may be involved in the mechanisms of irAE development, there are a limited number of studies into their utility as predictive biomarkers of irAE development after ICB treatment. The gene discussed is CD74; the disease is autoimmune disease.